How Analysts Feel About DaVita Inc. (NYSE:DVA)?

August 9, 2018 - By Richard Slagle

DaVita Inc. (NYSE:DVA) LogoInvestors sentiment increased to 0.9 in 2018 Q1. Its up 0.16, from 0.74 in 2017Q4. It is positive, as 35 investors sold DaVita Inc. shares while 159 reduced holdings. 70 funds opened positions while 105 raised stakes. 145.68 million shares or 0.35% more from 145.16 million shares in 2017Q4 were reported.
Hillsdale Invest Management has invested 0.05% of its portfolio in DaVita Inc. (NYSE:DVA). Swiss Bankshares owns 470,418 shares. Kentucky Retirement System Tru Fund holds 0.04% or 3,333 shares in its portfolio. Artisan Lp owns 0.04% invested in DaVita Inc. (NYSE:DVA) for 297,449 shares. Prudential Inc stated it has 0.03% of its portfolio in DaVita Inc. (NYSE:DVA). Fjarde Ap invested in 46,829 shares or 0.05% of the stock. Coastline Tru, Rhode Island-based fund reported 18,990 shares. Dynamic Capital Limited invested in 8,087 shares. Whittier Of Nevada owns 3,895 shares for 0.02% of their portfolio. 56,422 were accumulated by Vident Invest Advisory Ltd Liability. Thompson Siegel & Walmsley Limited holds 0.01% of its portfolio in DaVita Inc. (NYSE:DVA) for 14,550 shares. Blackrock holds 12.37M shares. Captrust Financial Advisors has invested 0.01% of its portfolio in DaVita Inc. (NYSE:DVA). Chevy Chase Hldgs holds 0.04% in DaVita Inc. (NYSE:DVA) or 123,157 shares. Continental Advsr Limited Liability holds 2.02% in DaVita Inc. (NYSE:DVA) or 120,900 shares.

Since May 14, 2018, it had 0 insider purchases, and 3 sales for $211,988 activity. $86,918 worth of DaVita Inc. (NYSE:DVA) shares were sold by Arway Pamela M. The insider ROPER WILLIAM L sold 1,505 shares worth $102,677.

DaVita Inc. (NYSE:DVA) Ratings Coverage

Among 4 analysts covering DaVita (NYSE:DVA), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. DaVita had 5 analyst reports since February 13, 2018 according to SRatingsIntel. On Tuesday, April 17 the stock rating was maintained by SunTrust with “Hold”. The rating was maintained by RBC Capital Markets on Tuesday, February 13 with “Hold”. The rating was maintained by Robert W. Baird on Tuesday, February 13 with “Buy”. SunTrust maintained the stock with “Hold” rating in Wednesday, February 14 report. Below is a list of DaVita Inc. (NYSE:DVA) latest ratings and price target changes.

06/06/2018 Broker: William Blair Rating: Buy
17/04/2018 Broker: SunTrust Rating: Hold New Target: $70.0000 Maintain
14/02/2018 Broker: SunTrust Rating: Hold New Target: $80.0 Maintain
13/02/2018 Broker: Robert W. Baird Rating: Buy New Target: $97.0 Maintain
13/02/2018 Broker: RBC Capital Markets Rating: Hold New Target: $70.0 Maintain

It closed at $73.34 lastly. It is down 2.44% since August 9, 2017 and is uptrending. It has underperformed by 10.13% the S&P500.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease . The company has market cap of $12.24 billion. It operates through two divisions, DaVita Kidney Care and DaVita Medical Group. It has a 25.02 P/E ratio. The firm operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.

More recent DaVita Inc. (NYSE:DVA) news were published by: Bizjournals.com which released: “DaVita Inc. divests pharmacy assets to Walgreens” on July 30, 2018. Also Bizjournals.com published the news titled: “DaVita outsourcing most of pharmacy division” on August 02, 2018. Seekingalpha.com‘s news article titled: “DaVita (DVA) Q2 2018 Results – Earnings Call Transcript” with publication date: August 02, 2018 was also an interesting one.

DaVita Inc. (NYSE:DVA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.